AAA announces manufacturing and service agreement to supply Amyvid™ (Florbetapir (18F)) solution for injection in France, Italy and Spain May

Advanced Accelerator Applications (AAA) announces completion of €4.8 million capital increase

AAA strengthens European radiopharmaceutical manufacturing network – Acquires two well established companies in Spain

AAA enters Polish market following agreement with University of Warsaw

Start of Pivotal Phase III trial for Lutathera® in cancer patients with progressive midgut carcinoid

AAA announces strategic steps in the expansion of its European PET manufacturing network

AAA acquires rights to oncology antibody treatment FabOvar from Dompé

AAA announces completion of €40 million capital increase, Dompé acquires 7.7% stake, Eugenio Aringhieri joins AAA Board

Pierrel Research International AG has been awarded a conduction of a phase III study in the area of tumoral pathologies

Advanced Accelerator Applications receives GMP approval to manufacture Lutate for treatment of NeuroEndocrine Tumors